These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14689100)

  • 1. Abdominal fat and sympathetic overactivity. From calorie intake to postmenopausal hypertension.
    Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):668-73. PubMed ID: 14689100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women.
    Faria AN; Ribeiro Filho FF; Gouveia Ferreira SR; Zanella MT
    Obes Res; 2002 Dec; 10(12):1203-6. PubMed ID: 12490663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value and limitations of the body mass index (BMI) in the assessment of the health risks of overweight and obesity].
    Kok P; Seidell JC; Meinders AE
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2379-82. PubMed ID: 15615272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.
    Brochu M; Mathieu ME; Karelis AD; Doucet E; Lavoie ME; Garrel D; Rabasa-Lhoret R
    Obesity (Silver Spring); 2008 May; 16(5):1085-93. PubMed ID: 18356851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, hyperinsulinemia and hypertension.
    Weidmann P; de Courten M; Böhlen L
    J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic system activity in obesity and metabolic syndrome.
    Tentolouris N; Liatis S; Katsilambros N
    Ann N Y Acad Sci; 2006 Nov; 1083():129-52. PubMed ID: 17148737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of insulin sensitivity with fatness and fitness and in older men and women.
    Ouyang P; Sung J; Kelemen MD; Hees PS; DeRegis JR; Turner KL; Bacher AC; Stewart KJ
    J Womens Health (Larchmt); 2004 Mar; 13(2):177-85. PubMed ID: 15072732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome.
    Müller MJ; Lagerpusch M; Enderle J; Schautz B; Heller M; Bosy-Westphal A
    Obes Rev; 2012 Dec; 13 Suppl 2():6-13. PubMed ID: 23107255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and the metabolic syndrome.
    Johannsson G; Bengtsson BA
    J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in sympathetic activity in obesity and its related hypertension.
    Fu Q
    Ann N Y Acad Sci; 2019 Oct; 1454(1):31-41. PubMed ID: 31087350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and androgens in healthy women with different body fat distributions.
    Ivandić A; Prpić-Krizevac I; Bozić D; Barbir A; Peljhan V; Balog Z; Glasnović M
    Wien Klin Wochenschr; 2002 May; 114(8-9):321-6. PubMed ID: 12212367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of fat distribution on risk].
    Toplak H
    Acta Med Austriaca; 1998; 25(4-5):131-2. PubMed ID: 9879386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting energy expenditure, cardiovascular risk factors and insulin resistance in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Ann Nutr Metab; 2005; 49(6):381-5. PubMed ID: 16219989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melancholic depression and abdominal fat distribution: a mini-review.
    Mann JN; Thakore JH
    Stress; 1999 Aug; 3(1):1-15. PubMed ID: 19016189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial fat and its relationship to abdominal fat: a marker for insulin resistance?
    Sierra-Johnson J; Johnson BD
    Med Hypotheses; 2004; 63(5):783-6. PubMed ID: 15488647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between intra-abdominal fat and hypertension in android obese diabetics.
    Sepulveda-Lavados A; Bastard JP; Attal M; Belin MF; Sachon C; Verny C; Grimaldi A
    Ann Med Interne (Paris); 1996; 147(6):393-16. PubMed ID: 9092341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.